Zacks Research Issues Negative Outlook for Teleflex Earnings

Teleflex Incorporated (NYSE:TFX) – Equities research analysts at Zacks Research decreased their Q2 2025 earnings estimates for Teleflex in a research note issued on Thursday, March 6th. Zacks Research analyst R. Department now forecasts that the medical technology company will earn $3.36 per share for the quarter, down from their previous forecast of $3.71. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q3 2025 earnings at $3.74 EPS, Q4 2025 earnings at $4.17 EPS, Q2 2026 earnings at $3.77 EPS, Q3 2026 earnings at $3.94 EPS, Q4 2026 earnings at $3.80 EPS and FY2027 earnings at $14.39 EPS.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%.

Several other research firms have also recently weighed in on TFX. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and dropped their price objective for the stock from $220.00 to $155.00 in a research note on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Piper Sandler reaffirmed a “neutral” rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Finally, Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Stock Performance

NYSE:TFX opened at $140.24 on Friday. The stock has a 50 day simple moving average of $171.13 and a 200 day simple moving average of $201.30. The stock has a market cap of $6.50 billion, a P/E ratio of 27.88, a PEG ratio of 1.73 and a beta of 1.21. Teleflex has a 1-year low of $128.55 and a 1-year high of $249.90. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37.

Institutional Trading of Teleflex

Several large investors have recently bought and sold shares of TFX. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Teleflex by 72.7% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 3,177 shares of the medical technology company’s stock worth $786,000 after acquiring an additional 1,337 shares during the last quarter. Janney Montgomery Scott LLC increased its position in Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after purchasing an additional 65 shares in the last quarter. Robeco Institutional Asset Management B.V. bought a new position in Teleflex in the 3rd quarter valued at approximately $687,000. QRG Capital Management Inc. acquired a new stake in Teleflex in the third quarter valued at approximately $509,000. Finally, Principal Financial Group Inc. grew its stake in shares of Teleflex by 2.7% during the third quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company’s stock worth $19,887,000 after buying an additional 2,086 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.97%. Teleflex’s payout ratio is 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.